RxSearch

NDC properties for "Hyrimoz 40 MG per 0.4 ML Prefilled Syringe" (RxCUI 2641661)

About this data

The tables show NDC propoerties for Hyrimoz 40 MG per 0.4 ML Prefilled Syringe with the RxCUI 2641661

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product

Details for Hyrimoz 40 MG per 0.4 ML Prefilled Syringe (RxCUI 2641661)

BLABLA761071
MMSL_CODEBD39595
RxCUI2641661
SPL_SET_ID1ac7d061-3380-468c-b077-c05f8dfbc829
SPL_SET_ID3e303a4a-980b-4f2a-9d03-786928758637
Prescribable SynonymHyrimoz 40 MG in 0.4 ML Prefilled Syringe
RXNAV_STRHyrimoz 40 MG per 0.4 ML Prefilled Syringe
RxNorm Name0.4 ML adalimumab-adaz 100 MG/ML Prefilled Syringe [Hyrimoz]
RxNorm SynonymHyrimoz 40 MG per 0.4 ML Prefilled Syringe
Related queriesInteractions (for RxCUI 2641661)



NDC Properties

NDC Item 61314047364

NDC 961314-473
NDC 1061314-473-64
NDC Item61314047364
Packaging2 SYRINGE, GLASS in 1 CARTON (61314-473-64) / .4 mL in 1 SYRINGE, GLASS
BLABLA761071
FDA SPL set id782789
LabelerSandoz Inc
Label typeHUMAN PRESCRIPTION DRUG
Marketing categoryBLA
Marketing effective time low2023-07-01
Marketing statusACTIVE
Related queriesProperties for NDC 9 61314-473

NDC Item 83457010101

NDC 983457-101
NDC 1083457-101-01
NDC Item83457010101
Packaging2 SYRINGE, GLASS in 1 CARTON (83457-101-01) / .4 mL in 1 SYRINGE, GLASS
BLABLA761071
FDA SPL set id782641
LabelerCordavis Limited
Label typeHUMAN PRESCRIPTION DRUG
Marketing categoryBLA
Marketing effective time low2023-09-21
Marketing statusACTIVE
Related queriesProperties for NDC 9 83457-101

NDC Item 83457020146

NDC 983457-201
NDC 1083457-201-46
NDC Item83457020146
Related queriesProperties for NDC 9 83457-201

NDC Item 61314047364

NDC 961314-473
NDC 1061314-473-64
NDC Item61314047364
Packaging2 SYRINGE, GLASS in 1 CARTON (61314-473-64) / .4 mL in 1 SYRINGE, GLASS
BLABLA761071
FDA SPL set id782789
LabelerSandoz Inc
Label typeHUMAN PRESCRIPTION DRUG
Marketing categoryBLA
Marketing effective time low2023-07-01
Marketing statusACTIVE
Related queriesProperties for NDC 9 61314-473

NDC Item 83457010101

NDC 983457-101
NDC 1083457-101-01
NDC Item83457010101
Packaging2 SYRINGE, GLASS in 1 CARTON (83457-101-01) / .4 mL in 1 SYRINGE, GLASS
BLABLA761071
FDA SPL set id782641
LabelerCordavis Limited
Label typeHUMAN PRESCRIPTION DRUG
Marketing categoryBLA
Marketing effective time low2023-09-21
Marketing statusACTIVE
Related queriesProperties for NDC 9 83457-101

NDC Item 83457020146

NDC 983457-201
NDC 1083457-201-46
NDC Item83457020146
Related queriesProperties for NDC 9 83457-201

NDC Item 61314047364

NDC 961314-473
NDC 1061314-473-64
NDC Item61314047364
Packaging2 SYRINGE, GLASS in 1 CARTON (61314-473-64) / .4 mL in 1 SYRINGE, GLASS
BLABLA761071
FDA SPL set id782789
LabelerSandoz Inc
Label typeHUMAN PRESCRIPTION DRUG
Marketing categoryBLA
Marketing effective time low2023-07-01
Marketing statusACTIVE
Related queriesProperties for NDC 9 61314-473

NDC Item 83457010101

NDC 983457-101
NDC 1083457-101-01
NDC Item83457010101
Packaging2 SYRINGE, GLASS in 1 CARTON (83457-101-01) / .4 mL in 1 SYRINGE, GLASS
BLABLA761071
FDA SPL set id782641
LabelerCordavis Limited
Label typeHUMAN PRESCRIPTION DRUG
Marketing categoryBLA
Marketing effective time low2023-09-21
Marketing statusACTIVE
Related queriesProperties for NDC 9 83457-101

NDC Item 83457020146

NDC 983457-201
NDC 1083457-201-46
NDC Item83457020146
Related queriesProperties for NDC 9 83457-201